STLN
The Oncology Institute, Inc.
6.20$
-1.7%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | +28.4% | +21.3% | +27.8% | |
| – | +32.1% | +28.2% | +25.6% | |
| – | +14.4% | -9.4% | +41.6% | |
| – | -4.9% | -5.3% | -2.1% | |
| – | +18.5% | +18.0% | -75.2% | |
| – | – | – | – | |
| – | +66.0% | +10.6% | +50.4% | |
| – | – | – | – | |
| – | – | – | – | |
| – | -54,750.0% | – | – | |
| – | -938.5% | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.